Analysis and classification of interval cancers in a French breast cancer screening programme (departement of Isere)

European Journal of Cancer Prevention

Volumn 8, Issue 3, 1999, Pages 255-260

  Exbrayat, C ^a,b   Garnier, A ^b   Colonna, M ^a   Assouline, D ^a,c   Salicru, B ^b,c   Winckel, P ^b,c   Menegoz, F ^a   Bolla, M ^b,d  

^a Registre du Cancer de l'Isere   (France)

^b Off Departemental de L   (France)

^c Clinique du Mail   (France)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Breast; Cancer; Interval; Mass screening

Indexed keywords

ARTICLE; BREAST CANCER; CALCULATION; CANCER INCIDENCE; CANCER SCREENING; DIAGNOSTIC VALUE; EVALUATION; HUMAN; PRIORITY JOURNAL;

EID: 0032755110     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199906000-00014     Document Type: Article

References (16)

1. Burhenne HJ, Burhenne LW, Goldberg F et al. (1994). Interval breast cancers in the screening mammography programme of British Columbia: analysis and classification. AJR 162: 1067-71.
2. Ciatto S, Rossclli Del Turco L, Zapa M (1905). The detectability of breast cancer by screening mammography. Br J Cancer 71: 337-9.
3. Day NE (1985). Estimating the sensitivity of a screening test. J Epidemiol Community Health 39: 364-6.
4. Duffy SW, Chen HH, Tabar L et al. (1996). Sojourn time, sensitivity and positive predictive value of mammography screening for breast cancer in women aged 40-49. Int J Epidemiol 26. 1139-45.
5. Esteve J, Benhamou E, Raymond L (1993). Statistical methods in cancer research. Vol IV. Descriptive Epidemiology. London: IARC Scientific Publication No 128.
6. Exbrayat C, Garnier A, Bolla M et al. (1996), Dépistage simultané des cancers du sein, du col utérin, du côlon et du rectum. Expérience de l'Isère. Bull Cancer 83: 641-8.
7. Ikeda DM, Andersson I, Wattsgard C et al. (1992). Interval carcinomas in the Malmö mammographic screening trial: radiographic appearance and prognostic considerations. AJR 159: 287-92.
8. Klemi PJ, Toikkanen S, Räsänen O et al. (1997). Mammography screening interval and the frequency of interval cancers in a population-based screening. Br J Cancer 75: 762-6.
9. Koivunen D, Zhang X, Blackwell C et al. (1994). Interval breast cancers are not biologically distinct - just more difficult to diagnose. Am J Surg 169: 538-42.
10. Lacour A, Mamelle N, Lafont S et al. (1997). The use of mammography as a breast cancer screening tool in five regions in France. Cancer Detect Prev 21(5): 460-70.
11. Moss SM, Coleman DA, Ellman R et al. (1993). Interval cancers and sensitivity in the screening centres of the UK trial of early detection of breast cancer. Eur J Cancer 29A: 255-8.
12. Peeters PHM, Verbeck ALM, Hendriks JHCL et al. (1989). The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer 59: 929-32.
13. Sibbering DM, Burrell HC, Evans AJ et al. (1995). Mammographic sensitivity in women under 50 years presenting symptomatically with breast cancer. Breast 4: 127-9.
14. Tabar L, Faberger G, Day NE et al. (1987). What is the optimum interval between mammgoraphic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer 55: 547-51.
15. Van Dijck JAAM, Verbeek ALM, Hendriks JHCL et al. (1993). The current detectability of breast cancer in a mammographic screening programme. Cancer 72: 1933-8.
16. Woodman CBJ, Anthony AG, Boggis CRM et al. (1995). Is the three-year breast cancer interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ 310: 224-6.